Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators.

Lagerqvist B, Säfström K, Ståhle E, Wallentin L, Swahn E; FRISC II Study Group Investigators..

J Am Coll Cardiol. 2001 Jul;38(1):41-8.

2.

Gender differences in the outcome of cardiac interventions.

Tillmanns H, Waas W, Voss R, Grempels E, Hölschermann H, Haberbosch W, Waldecker B.

Herz. 2005 Aug;30(5):375-89. Review. English, German.

PMID:
16132240
3.

Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease.

Johnston N, Jernberg T, Lagerqvist B, Wallentin L.

Am Heart J. 2006 Dec;152(6):1052-8.

PMID:
17161052
4.

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study.

Lagerqvist B, Husted S, Kontny F, Näslund U, Ståhle E, Swahn E, Wallentin L; Fast Revascularization during InStability in Coronary artery disease-II Investigators..

J Am Coll Cardiol. 2002 Dec 4;40(11):1902-14.

6.

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy.

Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, Avorn J.

J Am Coll Cardiol. 2001 Oct;38(4):969-76.

7.

The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.

Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Venge P, Wallentin L; Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators..

Am Heart J. 2002 May;143(5):760-7.

PMID:
12040335
8.
9.

Improving outcomes in acute coronary syndromes--the FRISC II trial.

Kontny F.

Clin Cardiol. 2001 Mar;24(3 Suppl):I3-7.

10.

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.

Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, Stridsberg M, Venge P, Wallentin L.

J Am Coll Cardiol. 2003 Dec 3;42(11):1909-16.

11.

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.

Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Wallentin L.

Am J Med. 2003 Dec 1;115(8):606-12.

PMID:
14656612
12.

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy.

Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L; FRISC II(Fast Revascularization during InStability in CAD) Investigators..

J Am Coll Cardiol. 2001 Oct;38(4):979-86.

14.

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L, Wallentin L.

J Am Coll Cardiol. 2004 Feb 18;43(4):585-91.

16.
17.

Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators.

Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Arnold A, Sapp SK, Booth JE, Ferguson JJ, Cannon CP.

Am J Cardiol. 1999 Nov 15;84(10):1145-50.

PMID:
10569321
19.
20.

FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease.

Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Ståhle E, Swahn E, Venge P, Siegbahn A, Wallentin L.

Heart. 2005 Aug;91(8):1047-52.

Items per page

Supplemental Content

Support Center